Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-25-040627)

Filing Details

Accession Number:: 0001213900-25-040627
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-05-07 16:05:15
Reporting Period:: 2025-05-05

Filing Date:: 2025-05-07
Accepted Time:: 2025-05-07 16:05:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1845459	Nkgen Biotech Inc.	NKGN	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1991119	Y. Paul Song	Nkgen Biotech, Inc. 3001 Daimler Street Santa Ana CA 92705	Chief Executive Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-05-05	20,849,725	$0.13	21,020,846	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Acquisiton	2025-05-05	41,699,449	$0.13	41,699,449	$0.13

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
41,699,449	2025-05-05	2030-05-05	No	4	P	Direct

Footnotes

On May 5, 2025, the Reporting Person purchased 20,849,725 shares of common stock of the Company, $0.0001 par value per share ("Common Stock") pursuant to that certain Securities Purchase Agreement (the "SPA").
On May 5, 2025, the Reporting Person purchased 41,699,449 warrants to purchase shares of Common Stock in connection with the SPA and pursuant to that certain Common Stock Purchase Warrant.